KF
NVAX icon

Krilogy Financial’s Novavax NVAX Stock Holding History

Krilogy Financial’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,700
Closed -$352K – 285
2021
Q3 		$352K Buy
+1,700
New +$375K 0.04% 211
2017
Q3 		– Sell
-10
Closed – – 834
2017
Q2 		$0 Hold
10
– – ﹤0.01% 763
2017
Q1 		$0 Hold
10
– – ﹤0.01% 718
2016
Q4 		$0 Hold
10
– – ﹤0.01% 746
2016
Q3 		$0 Hold
10
– – ﹤0.01% 761
2016
Q2 		$1K Hold
10
– – ﹤0.01% 723
2016
Q1 		$1K Buy
+10
New +$1.07K ﹤0.01% 647

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Krilogy Financial's NVAX Position: Q4 2021 in Review

Krilogy Financial sold out of Novavax (NVAX) in Q4 2021, closing a stake of 1,700 shares — an estimated $352K sold.

Krilogy Financial first reported a position in NVAX in Q1 2016 and held it in 7 quarters. The position peaked at $352K in Q3 2021. 429 funds tracked by Wall St. Rank hold NVAX as of Q4 2021.

  • Krilogy Financial reported no remaining Novavax position as of Q4 2021 after selling out during the quarter.
  • Krilogy Financial sold 1,700 Novavax shares in Q4 2021, an estimated $352K.
  • Krilogy Financial first reported a position in Novavax in Q1 2016 and held it in 7 quarters.
  • Krilogy Financial's Novavax position peaked at $352K in Q3 2021.
  • 429 funds tracked by Wall St. Rank held Novavax as of Q4 2021.

Based on Krilogy Financial's 13F filing for Q4 2021, filed 27 Jan 2022.